Impact of Blood Pressure Management on Cardiovascular Events in Patients With Familial Hypercholesterolemia

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
Hayato Tada MD , Nobuko Kojima MD , Yasuaki Takeji MD , Atsushi Nohara MD , Masa-Aki Kawashiri MD , Masayuki Takamura MD
{"title":"Impact of Blood Pressure Management on Cardiovascular Events in Patients With Familial Hypercholesterolemia","authors":"Hayato Tada MD ,&nbsp;Nobuko Kojima MD ,&nbsp;Yasuaki Takeji MD ,&nbsp;Atsushi Nohara MD ,&nbsp;Masa-Aki Kawashiri MD ,&nbsp;Masayuki Takamura MD","doi":"10.1016/j.amjcard.2024.09.021","DOIUrl":null,"url":null,"abstract":"<div><div>Hypertension has been associated with worse outcomes in patients with familial hypercholesterolemia (FH). We aimed to identify the clinical impact of blood pressure management on the development of cardiovascular events. We assessed patients with clinically diagnosed heterozygous FH (n = 1,273, male/female = 614/659) with blood pressure data. We categorized them into 4 groups (group 1: patients without hypertension from baseline to follow-up; group 2: patients without hypertension at baseline but in whom hypertension developed at follow-up; group 3: patients with hypertension at baseline that was well-controlled at follow-up; group 4: patients with hypertension from baseline that was uncontrolled at follow-up). We used Cox proportional hazards models to evaluate factors associated with cardiovascular events, including cardiovascular death and any coronary events. The median follow-up period was 10.9 years. We observed 142 cardiovascular events during the follow-up period and revealed that blood pressure management was significantly associated with cardiovascular event occurrence (hazard ratio [HR] 2.50, 95% confidence interval [CI] 1.30 to 3.70, p &lt;0.001; HR 4.18, 95% CI 2.08 to 6.28, p &lt;0.001; HR 10.96, 95% CI 6.10 to 17.58, p &lt;0.001 in groups 2, 3, and 4, respectively, with group 1 as reference). In conclusion, blood pressure management is crucial in patients with heterozygous FH.</div></div>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002914924006994","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Hypertension has been associated with worse outcomes in patients with familial hypercholesterolemia (FH). We aimed to identify the clinical impact of blood pressure management on the development of cardiovascular events. We assessed patients with clinically diagnosed heterozygous FH (n = 1,273, male/female = 614/659) with blood pressure data. We categorized them into 4 groups (group 1: patients without hypertension from baseline to follow-up; group 2: patients without hypertension at baseline but in whom hypertension developed at follow-up; group 3: patients with hypertension at baseline that was well-controlled at follow-up; group 4: patients with hypertension from baseline that was uncontrolled at follow-up). We used Cox proportional hazards models to evaluate factors associated with cardiovascular events, including cardiovascular death and any coronary events. The median follow-up period was 10.9 years. We observed 142 cardiovascular events during the follow-up period and revealed that blood pressure management was significantly associated with cardiovascular event occurrence (hazard ratio [HR] 2.50, 95% confidence interval [CI] 1.30 to 3.70, p <0.001; HR 4.18, 95% CI 2.08 to 6.28, p <0.001; HR 10.96, 95% CI 6.10 to 17.58, p <0.001 in groups 2, 3, and 4, respectively, with group 1 as reference). In conclusion, blood pressure management is crucial in patients with heterozygous FH.
血压管理对家族性高胆固醇血症患者心血管事件的影响:家族性高胆固醇血症患者中的高血压
高血压与家族性高胆固醇血症(FH)患者的不良预后有关。我们旨在确定血压管理对心血管事件发展的临床影响。我们对临床诊断为杂合性 FH(HeFH)的患者(人数=1,273,男性/女性=614/659)进行了血压数据评估。我们将他们分为四组(第 1 组:从基线到随访期间均无高血压的患者;第 2 组:基线时无高血压,但随访时出现高血压的患者;第 3 组:基线时有高血压,但随访时血压控制良好的患者;第 4 组:基线时有高血压,但随访时血压未得到控制的患者)。我们使用 Cox 比例危险模型来评估与心血管事件(包括心血管死亡和任何冠状动脉事件)相关的因素。随访时间的中位数为 10.9 年。我们在随访期间观察到 142 起心血管事件,结果显示,血压管理与心血管事件的发生显著相关(危险比 [HR]:2.50,95% 置信区间 [CI]:1.30-3.70,P<0.05):1.30-3.70,p <0.001;HR:4.18,95% 置信区间:2.08-6.28,p <0.001;HR:10.96,95% 置信区间:6.10-17.58,p <0.001,分别在第 2、3 和 4 组,以第 1 组为参照)。总之,血压管理对 HeFH 患者至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信